I am a neurologist and cancer doctor who treats brain tumors and researches ways to improve quality of life for brain tumor patients. As a college student, I thought I was going to be a scientist, but fell in love with studying the brain and its inner workings. I enjoy being at Duke, because I work with some of the top clinicians and researchers in the field, and a generous and warm-hearted staff that helps patients and their loved ones through treatment. It is hard to pick one thing I enjoy about my job. I enjoy seeing patients and their loved ones, being at the cutting edge of research and teaching the next generation of doctors. I think it is the chance to do so many different things that makes my job special. Outside of work, I enjoy shopping at farmer’s markets, cooking and exercising. I also collect Swatch watches - I have over 400!. Dr. Peters is rated as an Elite provider by MediFind in the treatment of Glioma. Her top areas of expertise are Glioma, Gliomatosis Cerebri, Brain Tumor, and Astrocytoma.

I am an academic adult and pediatric neuro-oncologist who helps lead The Preston Robert Tisch Brain Tumor Center at Duke. I am the author of more than 500 peer-reviewed articles, reviews, and book chapters, and I have presented extensively at both international and national meetings. I am a committed educator who is a member of the executive and super-executive committees of the Duke University School of Medicine, which are responsible for the recruitment, screening and selection of medical students. I have reviewed grants for the National Institutes of Health for over 15 years, in a spectrum of different study sections. I am the senior editor of CNS Oncology and a reviewer for over 25 academic journals. I serve on the advisory board of a number of organizations, including Voices Against Brain Cancer, the Tug McGraw Foundation, Pinnacle Care, the Pediatric Brain Tumor Foundation, the National Children’s Cancer Society, and the American Brain Tumor Association. Dr. Friedman is rated as an Elite provider by MediFind in the treatment of Glioma. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, and Brain Tumor.

What we specialize in at The Preston Robert Tisch Brain Tumor Center is compassionate care – we take care of our patients. It’s complete care. The patients don’t have to go out and find a radiologist. We have the radiation oncologist, the chemotherapy, the surgery, the radiology, we have all kinds of nursing people as well as help getting physical therapy and getting in-the-home assistance. Patients also can expect cutting-edge care because we run such a terrific science program here. I really like working with the patients. No question about it. It’s not that I’m doing some trivial procedure six times a day. When someone comes in with a brain tumor, there’s usually some bonding, and instead of running away from that, I really enjoy it. Dr. Friedman is rated as an Elite provider by MediFind in the treatment of Glioma. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, Awake Craniotomy, and Laminectomy.

I'm a radiation oncologist, and I specialize in treating brain, base of skull and spine tumors, as well as tumors that arise in the body but go to the brain or the spine, as in certain cases of lung, breast and kidney cancer and melanoma. When I meet with a patient, it’s important for me to introduce them and their family to our team of doctors, therapists, nurses and treatment planners. The patient and their family will also become members of this team – truly the most important part - so we can work together to tailor care based on their wants and needs. At Duke, we’ve developed techniques to precisely and accurately treat small, complex lesions and tumors. We can minimize the amount of radiation that goes into normal tissues and at the same time maximize the amount of radiation where it is needed. Our team is geared to delivering every treatment to each patient exactly as planned, especially in complicated and difficult situations. As a patient or a physician, I think there’s no better place to be than Duke. I love my work, feel honored that my patients place their trust in our team and me and work hard to earn that trust. Dr. Kirkpatrick is rated as an Elite provider by MediFind in the treatment of Glioma. His top areas of expertise are Brain Tumor, Meningioma, Glioma, Astrocytoma, and Gamma Knife Radiosurgery.

Glenn Lesser is an Oncologist and a Hematologist in Winston Salem, North Carolina. Dr. Lesser is rated as an Elite provider by MediFind in the treatment of Glioma. His top areas of expertise are Brain Tumor, Glioblastoma, Astrocytoma, Glioma, and Bone Marrow Aspiration. Dr. Lesser is currently accepting new patients.

Howard Safran is a Hematologist Oncology specialist and a Hematologist in Providence, Rhode Island. Dr. Safran is rated as an Elite provider by MediFind in the treatment of Glioma. His top areas of expertise are Pancreatic Cancer, Gastroesophageal Junction Cancer, Colorectal Cancer, Stomach Cancer, and Pancreaticoduodenectomy.

John De Groot is a Neurologist in San Francisco, California. Dr. De Groot is rated as an Elite provider by MediFind in the treatment of Glioma. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Marta Penas-Prado is a Neurologist in Houston, Texas. Dr. Penas-Prado is rated as an Elite provider by MediFind in the treatment of Glioma. Her top areas of expertise are Astrocytoma, Glioblastoma, Brain Tumor, and Glioma.

John Golfinos is a Neurosurgery provider in New York, New York. Dr. Golfinos is rated as an Elite provider by MediFind in the treatment of Glioma. His top areas of expertise are Acoustic Neuroma, Schwannoma, Meningioma, Gamma Knife Radiosurgery, and Awake Craniotomy.

Peter Forsyth is a Neurologist in Tampa, Florida. Dr. Forsyth is rated as an Elite provider by MediFind in the treatment of Glioma. His top areas of expertise are Brain Tumor, Glioma, Gliomatosis Cerebri, Metastatic Brain Tumor, and Awake Craniotomy. Dr. Forsyth is currently accepting new patients.

Dr. Jaishri Blakeley is the Marjorie Bloomberg Tiven Professor of Neurofibromatosis in Neurology, Oncology, and Neurosurgery at Johns Hopkins School of Medicine, director of the Johns Hopkins Comprehensive Neurofibromatosis Center and director of the Neurofibromatosis Therapeutic Acceleration Program (NTAP). She is an active clinician-scientist specializing in the care of people with NF1, NF2, LZTR1, SMARC1 schwannomatoses, and primary brain tumors. Her research expertise in the development of clinical trials for nervous system tumors and specifically, early clinical-translational studies including tumor pharmacokinetic and pharmacodynamic investigations, imaging biomarkers for rare nervous system tumors, and incorporation of patient-focused, functional endpoints into efficacy studies. She has been the national or international leader of 7 clinical trials focused on therapies for glioblastoma, NF1 and NF2. In 2012 she cofounded the NTAP to dramatically shift the landscape of NF1 via necessary, efficient, and expert discovery, translational and clinical research. NTAP focuses on therapeutics, fosters collaboration, facilitates open and timely sharing of results, and streamlines the research process to accelerate therapies for plexiform and cutaneous neurofibromas. Through NTAP, Dr. Blakeley has supported and collaborated with more than 80 laboratories and research teams across the globe enabling meaningful therapeutic development for NF1-associated neoplasms and supporting the development of an exceptional community of clinician scientists focused on NF1 via the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research. Her research and programmatic efforts are all in the service of improving outcomes for the patients with NF1, NF2, schwannomatosis, and primary brain cancer for whom she is honored to provide care. Dr. Blakeley is rated as an Elite provider by MediFind in the treatment of Glioma. Her top areas of expertise are Neurofibromatosis, Schwannomatosis, Neurofibromatosis Type 2 (NF2), Neurofibromatosis Type 1 (NF1), and Laminectomy.

David Peereboom is an Oncologist and a Hematologist Oncology provider in Cleveland, Ohio. Dr. Peereboom is rated as an Elite provider by MediFind in the treatment of Glioma. His top areas of expertise are Brain Tumor, Glioblastoma, Glioma, Astrocytoma, and Bone Marrow Aspiration.

Jeffrey Olson is a Neurosurgery provider in Atlanta, Georgia. Dr. Olson has been practicing medicine for over 45 years and is rated as an Elite provider by MediFind in the treatment of Glioma. His top areas of expertise are Glioblastoma, Astrocytoma, Gliosarcoma, Awake Craniotomy, and Nerve Decompression.

Rimas Lukas is a Hematologist Oncology specialist and a Neurologist in Chicago, Illinois. Dr. Lukas has been practicing medicine for over 24 years and is rated as an Elite provider by MediFind in the treatment of Glioma. His top areas of expertise are Astrocytoma, Glioma, Glioblastoma, Brain Tumor, and Gastrostomy.

Roger Stupp is a Hematologist Oncology specialist and a Neurologist in Chicago, Illinois. Dr. Stupp has been practicing medicine for over 39 years and is rated as an Elite provider by MediFind in the treatment of Glioma. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Brain Tumor.

Jan Drappatz, MD, is a neuro-oncologist, an associate professor at the University of Pittsburgh School of Medicine, and the director of the Neuro-oncology program at UPMC. Dr. Drappatz specializes in the treatment of primary and metastatic brain tumors and neurologic complications of cancer. Dr. Drappatz is rated as an Elite provider by MediFind in the treatment of Glioma. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri.

Samuel Chao is a Radiation Oncologist in Cleveland, Ohio. Dr. Chao has been practicing medicine for over 29 years and is rated as an Elite provider by MediFind in the treatment of Glioma. His top areas of expertise are Brain Tumor, Glioma, Astrocytoma, Glioblastoma, and Gamma Knife Radiosurgery.

Julie R. Brahmer, M.D., M.Sc. is the Director of the Thoracic Oncology Program, Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and the Marilyn Meyerhoff Professor in Thoracic Oncology. She also directs the Kimmel Cancer Center on the Johns Hopkins Bayview campus and is co-principal investigator on Johns Hopkins' National Clinical Trials Network. Dr. Brahmer received her undergraduate degree in Chemistry and Philosophy in 1989 from the Creighton University in Omaha, Nebraska and went on to receive her medical degree from the University of Nebraska Medical Center College of Medicine in 1993. Completing her internship and residency in Internal Medicine at the University of Utah, Dr. Brahmer later became the Chief Medical Resident until moving to Baltimore to complete her fellowship in Medical Oncology at the Kimmel Cancer Center at Johns Hopkins. Dr. Brahmer is an active clinical leader in the treatment of lung cancer and mesothelioma. She leads the organization of the multidisciplinary thoracic malignancy conference whose members meet weekly to discuss thoracic malignancy cases that need a multidisciplinary review/approach. Dr. Brahmer's research and clinical practice focuses on the development of new therapies for the treatment and prevention of lung cancer and mesothelioma. Dr. Brahmer's research interests include leading early phase immunotherapy trials of anti-PD-1 antibodies, international phase III studies of immunotherapies in lung cancer and investigator-initiated trials evaluating epigenetic therapies in combination with immunotherapies. She is a member of the American Society of Clinical Oncology and the Eastern Cooperative Oncology Group (ECOG) Thoracic Committee and Cancer Prevention Steering Committee. She is one of the founding Board members for the National Lung Cancer Partnership (formerly Women Against Lung Cancer). Within the National Lung Cancer Partnership, she currently serves as a member and the Chairman of the Scientific Executive Committee. She is also on the medical advisory board of the Lung Cancer Research Fund and the Mesothelioma Applied Research Foundation. Dr. Brahmer is rated as an Elite provider by MediFind in the treatment of Glioma. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).

John Boockvar is a Neurosurgery provider in New York, New York. Dr. Boockvar is rated as an Elite provider by MediFind in the treatment of Glioma. His top areas of expertise are Glioblastoma, Astrocytoma, Brain Tumor, Awake Craniotomy, and Laminectomy.

Joyce O'shaughnessy is an Oncologist and an Internal Medicine provider in Dallas, Texas. Dr. O'shaughnessy has been practicing medicine for over 44 years and is rated as an Elite provider by MediFind in the treatment of Glioma. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, HER2 Negative Breast Cancer, and Tissue Biopsy.